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HMG-CoA reductase, cholesterol 7-hydroxylase, LCAT, Nagase analbuminemic rats (NAR) were derived from
ACAT, LDL receptor, and SRB-1 in hereditary analbumi- Sprague Dawley strain by Sumi Nagase in 1979 [1]. Anal-
nemia. buminemia in the Nagase rats is caused by a defectiveBackground. Hereditary analbuminemia is associated with
albumin mRNA processing, resulting in exon skippinghypercholesterolemia, which has been shown to be primarily
and a virtual lack of albumin gene expression [2, 3].caused by increased extrahepatic production of cholesterol.
Nagase rats with hereditary analbuminemia (NAR) have been Hereditary analbuminemia is associated with hyper-
used as a model to dissect the effect of primary hypoalbumi- cholesterolemia and hypertriglyceridemia in both rats
nemia from that caused by proteinuria in nephrotic syndrome. [4, 5] and humans [6]. This is accompanied by significantThe present study was undertaken to explore the effect of
elevations of plasma Apo A1, Apo B, and Apo E concen-hereditary analbuminemia on protein expression of the key
factors involved in cholesterol metabolism. trations [7]. While less severe, alterations of plasma lipids
Methods. Hepatic tissue protein abundance of 3-hydroxy- and apoprotein profile in hereditary analbuminemia gen-
3-methylglutaryl coenzyme A (HMG-CoA) reductase, choles- erally resemble those seen in nephrotic syndrome, interol 7-hydroxylase (a rate-limiting enzyme in cholesterol ca-
which hypoalbuminemia is caused by albuminuria. Thetabolism), low density lipoprotein (LDL) receptor, high density
fact that the common denominator in both conditions islipoprotein (HDL) receptor (SRB-1), acyl-coA cholesterol
acyltransferase-2 (ACAT-2), and plasma concentration of leci- hypoalbuminemia and depressed plasma oncotic pres-
thin cholesterol acyltransferase (LCAT), as well as HMG-CoA sure suggests that increased lipid and apoprotein synthe-
reductase, ACAT, and LCAT activities were determined in sis may be, in part, mediated by hypoalbuminemia, asfasting male NAR and Sprague-Dawley control rats.
proposed by Marsh and Drabkin [8].Results. The NAR group exhibited significant up-regulation
of HMG-CoA reductase protein abundance but normal HMG- The liver plays a central role in regulation of choles-
CoA reductase enzymatic activity. This was coupled with a terol metabolism. The contribution of the liver to choles-
significant up-regulation of cholesterol 7-hydroxylase and a terol metabolism is multifaceted and includes its rolemild up-regulation of ACAT protein abundance and activity.
in biosynthesis of cholesterol and cholesterol-carryingHowever, hepatic LDL receptor and HDL receptor and plasma
apoproteins; catabolism of cholesterol to bile acids forLCAT protein concentration and activity were normal in NAR.
Conclusion. Hypercholesterolemia in NAR is associated disposal in the intestinal tract; receptor-mediated clear-
with elevated hepatic HMG-CoA reductase protein abun- ance of cholesterol-containing lipoproteins [low density
dance, but normal HMG-CoA reductase activity. These find- lipoprotein (LDL), high density lipoprotein (HDL), andings point to post-translational regulation of this enzyme and
intermediate density lipoprotein (IDL)]; and intracellu-favor an extrahepatic origin of hypercholesterolemia in NAR.
The observed up-regulation of cholesterol 7-hydroxylase rep- lar and extracellular esterification of cholesterol. Several
resents a compensatory response to the associated hypercholes- major proteins are involved in the above mentioned pro-
terolemia. Unlike nephrotic syndrome, which causes severe cesses, including 3-hydroxy-3-methylglutaryl-coenzymeLDL receptor, HDL receptor, and LCAT deficiencies, heredi-
A (HMG-CoA) reductase, which is the rate-limiting steptary analbuminemia does not affect these proteins.
in cholesterol synthesis; cholesterol 7-hydroxylase, the
rate-controlling enzyme in cholesterol catabolism to bile
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gated [5, 7], hepatic production of the majority of the 0.2 mol/L sucrose, 5 m phenylmethylsulfonyl fluoride,
enzymes and receptors listed above has not been ex- 5 g/mL leupeptin, 10 g/mL aprotinin, and 3 g/mL
plored. The present study was therefore undertaken to pepstatin A. The crude extract was centrifuged at 12,000g
determine immunodetectable abundance of HMG-CoA at 4C for 10 minutes to remove tissue debris. The super-
reductase, cholesterol 7-hydroxylase, LDL receptor, natant was processed for determination of HMG-CoA
HDL receptor, ACAT, and LCAT in the NAR and in reductase. Protein concentration of the supernatant was
normal Sprague-Dawley controls. In addition, enzymatic determined with a bicinchoninic acid (BCA) protein
activities of HMG-CoA reductase, ACAT, and LCAT assay kit (Pierce Inc., Rockford, IL, USA). HMG-CoA
were determined. reductase protein abundance in the liver extract was
quantified by Western blot analysis as described by Ness
et al [9]. Briefly, aliquots containing 100g proteins wereMETHODS
fractionated on 4-20% Tris-glycine gel (Novex, Inc., San
Animals
Diego, CA, USA) at 120 V for 2 hours. After electropho-
Male Nagase rats (SLC, Inc., Hamamatsu, Japan) and resis, proteins were transferred to Hybond-ECL mem-
age-matched male Sprague Dawley rats (Harlan Sprague- brane (Amersham Life Science, Inc., Arlington Heights,
Dawley, Inc., Indianapolis, IN, USA) with an average IL, USA). The membrane was incubated for 1 hour in
body weight of 180 g were employed in the study. The blocking buffer [1  tris-buffered saline (TBS), 0.1%
animals were housed in a climate-controlled, light-regu- Tween 20, and 7% nonfat milk] and then overnight in
lated space with 12-hour dark-light cycles. They were the same buffer containing 1:7500 polyclonal anti HMG-
provided access to regular rat chow (Purina Mills, Inc., CoA reductase antibody (generously provided by Profes-
Brentwood, MO, USA) and water ad libitum. The ani- sor Ness GC, Department of Biochemistry and Molecular
mals were maintained for 4 weeks, at which point they Biology, University of South Florida, Tampa, FL, USA).
were placed in individual metabolic cages for a 24-hour The membrane was washed four times for 10 minutes
urine collection. Animals were pair-fed during the last in 1  TBS, 0.1% Tween 20 prior to a 2-hour incubation
week of the observation period. No food was provided in blocking buffer plus diluted (1:10,000) horseradish per-
after 5 p.m. the day before sacrifice. However, water was oxidase–linked anti-rabbit immunoglobulin (Ig)G (Amer-
provided at all times. The animals were subsequently sham Life Science, Inc., Arlington Heights, IL, USA).
anesthetized with pentobarbitol 50 mg intraperitoneally
The washes were repeated before the membranes were
and euthanized by exsanguination using cardiac punc-
developed with chemiluminescent agents (ECL; Amer-ture between the hours of 9 and 11 a.m. The liver was
sham Life Science, Inc.) and subjected to autoluminogra-promptly removed and immediately frozen in liquid ni-
phy for 3 minutes.trogen and stored at70C until processing. In addition,
plasma was separated and stored at 70C. Six animals Determination of cholesterol 7-hydroxylase protein
were included in each group. The protocol employed in
Cholesterol 7-hydroxylase protein abundance in thethe study was approved by the institutional animal care
liver tissue preparation was determined by Western blotand use committee of the University of California, Irvine.
analysis using a rabbit anti-rat cholesterol 7-hydroxy-
lase antibody as described in our earlier studies [10]. TheMiscellaneous assays
antibody employed in this assay was generously providedUrine protein concentration was determined by a quanti-
by Professor John Y.L. Chiang (Northeastern Ohio Uni-tative colorimetric assay using a kit purchased from Sigma
versity College of Medicine).Chemical Company (St. Louis, MO, USA). Serum albu-
min concentration was quantified by bromocresol green Determination of LDL receptor protein
method employing a kit purchased from Wako Chemi-
Hepatic LDL receptor protein abundance was deter-cals USA, Inc. (Richmond, VA, USA). A colorimetric
mined in the plasma membrane preparation by Westernassay (Sigma Chemical Company) was used to measure
blot analysis using a mouse antibovine LDL receptorserum and urine creatinine concentrations. Plasma concen-
antibody (Cortex Biochem, Inc., Davis, CA, USA) astrations of total cholesterol and hepatic tissue free choles-
described in our previous study [11].terol were measured by enzymatic colorimetric assays
using kits supplied by Wako Chemicals USA, Inc. Plasma
Determination of ACAT-2 proteinHDL and LDL cholesterol concentrations and triglycer-
Hepatic acyl-coA cholesterol acyltransferase-2 (ACAT-2)ide levels were determined by kits purchased from Sigma
protein abundance was quantified by Western analysisChemical Company.
using a polyclonal antibody against ACAT-2 as described
HMG-CoA reductase protein determination in our recent study [12]. The antibody employed in these
experiments was a generous gift from Professor Law-Frozen rat liver tissue was homogenized in 1 mL of
20 mmol Tris-HCl (pH 7.5) buffer containing 2m MgCl2, rence L. Rudel, Department of Biochemistry and Com-
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parative Medicine, Wake Forest University, Winston- NAR group showed significantly higher serum total cho-
lesterol and triglyceride levels compared to the corre-Salem, NC.
sponding values in the control group. Likewise, LDL-
Determination of plasma LCAT protein cholesterol and very low density lipoprotein (VLDL)
cholesterol levels were higher in the NAR group thanPlasma lecithin cholesterol acyltransferase (LCAT)
protein concentration was measured in triplicate by en- in the control animals. However, HDL/total cholesterol
ratios were similar in the two groups. Liver tissue freezyme-linked immunosorbent assay (ELISA) using rabbit
anti-human LCAT antibody as described by Wang et al cholesterol concentration in the NAR group was two-
fold greater than that in the normal control group.[13]. This antibody was generously supplied by Professor
John S. Parks, Wake Forest University, Winston-Salem,
HMG-CoA reductase dataNC. Briefly, 10 L of plasma were diluted in binding
buffer (1  TBS, 0.05% NaN3, 200 L final volume) As illustrated in Figure 1, hepatic tissue HMG-CoA
reductase protein abundance in the NAR group was two-and incubated at 4C overnight in microtiter plates. The
wells were washed 3 times with washing buffer (1  fold greater than that found in the control group. In
contrast, hepatic HMG-CoA reductase activity in theTBS and 0.05% Tween 20), blocked for 3 hours at room
temperature with blocking buffer [0.5% bovine serum NAR group was similar to that found in the control
group. These findings point to posttranslational regula-albumin (BSA) and 0.05% Tween 20 in 1  TBS), and
washed. A 1:2000 dilution of rabbit anti-human LCAT tion of this enzyme.
antibody in blocking buffer were added to the well and
Cholesterol 7-hydroxylase dataincubated at room temperature for 3 hours. The plates
were washed and incubated with 1:2000 anti-rabbit IgG Results are shown in Figure 2. The NAR group showed a
conjugated with horseradish peroxidase (HRP) (Sigma significant up-regulation of hepatic cholesterol 7-hydroxy-
Chemical Co.), developed with 1-StepTM Turbo-TMB- lase when compared with that found in the control group.
ELISA kit (Pierce, Inc.), and read at 450 nm after the A significant correlation was found between liver tissue
color developed. Purified human plasma LCAT was used cholesterol 7-hydroxylase abundance and liver-free
as standard for the assay. cholesterol concentration (r  0.74, P  0.05).
Determination of HDL receptor (SRB-1) LDL-receptor and SRB-1 data
SRB-1 protein abundance in the plasma membrane Data depicted in Figures 3 and 4 illustrate that no
preparation of the liver was quantified by Western analy- significant difference was found in hepatic tissue LDL re-
sis using a polyclonal antibody against SRB-1 (Novus ceptor protein abundance between the NAR and the con-
Biological, Inc., Littleton, CO, USA) as described in our trol groups. Likewise, liver tissue abundance of SRB-1,
previous study [14]. otherwise known as HDL receptor, was virtually identi-
cal in the two groups.
Determination of enzymatic activities
ACAT dataEnzymatic activities of hepatic HMG-CoA reductase
and ACAT, as well as plasma LCAT were determined As presented in Figure 5, liver tissue ACAT-2 protein
by use of methods that were described in our earlier abundance and ACAT enzymatic activity were mildly
studies [12, 15, 16]. elevated in the NAR rats as compared to that found in
the Sprague Dawley control rats.
Data analysis
Plasma LCAT dataStudent t test and regression analysis were used in
statistical analysis of the data, which are presented as Data are shown in Figure 6. No significant difference
mean  SE. P values less than 0.05 were considered was found in plasma LCAT protein abundance between
significant. the NAR and Sprague Dawley control rats. Likewise,
plasma LCAT enzymatic activity was similar in the two
groups.RESULTS
General data
DISCUSSIONData are shown in Table 1. As expected, serum albu-
The male NAR rats employed in the present studymin concentration in the NAR group was severely re-
exhibited a significant increase in hepatic tissue HMG-duced compared with the normal control group. Urinary
CoA reductase protein abundance. However, HMG-protein excretion in the NAR group was minimal and
CoA reductase enzymatic activity was normal in thevirtually identical to that in the control group. Likewise,
creatinine clearance was similar in the two groups. The NAR group. The observed discordance between hepatic
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Table 1. Serum concentrations of total cholesterol, triglycerides, VLDL-cholesterol and albumin, serum HDL-chol/total
cholesterol ratio, creatinine clearance, urinary protein excretion, and liver tissue free cholesterol content in male
Sprague-Dawley control and Nagase analbuminemic rats (NAR)
Groups Control (N  6) NAR (N  6) P value
Serum cholesterol mg/dL 67.43.9 112.73.5 0.01
Serum LDL mg/dL 36.94.0 52.53.8 0.01
Serum VLDL mg/dL 10.41.5 23.62.7 0.01
HDL/cholesterol (ratio) 0.30.05 0.30.06 NS
Serum triglycerides mg/mL 50.86.5 81.47.9 0.01
Liver free cholesterol mg/g protein 16.10.6 31.31.2 0.01
Serum albumin g/dL 3.90.05 0.130.02 0.001
Creatinine clearance mL/min 1.20.1 1.30.1 NS
Urine protein mg/24 hr 7.71.0 8.21.0 NS
Fig. 2. Representative Western blot and group data depicting choles-
terol 7-hydroxylase (CH-7) protein abundance in the liver of Nagase
rats with inherited analbuminemia (NAR) and Sprague Dawley control
(CTL) rats. N  6 in each group; *P  0.05.
Earlier studies by our group demonstrated up-regula-
tion of HMG-CoA reductase mRNA, enzymatic activity,
and immunoreactive protein in the liver of rats with
Fig. 1. Representative Western blot and group data depicting HMG- puromycin-induced nephrotic syndrome [15] and in theCoA reductase protein abundance and enzymatic activity in the liver of
Imai rats with spontaneous focal glomerulosclerosis [18].Nagase rats with inherited analbuminemia (NAR) and Sprague Dawley
control (CTL) rats. N  6 in each group; *P  0.01. However, up-regulation of hepatic HMG-CoA reductase
protein expression in our rats with hereditary analbumi-
nemia was accompanied by normal HMG-CoA reduc-
tase activity. Using tritiated water incorporation, JolesHMG-CoA reductase protein abundance and its enzy-
et al [19] demonstrated a fourfold increase in 3H incorpo-matic activity points to posttranslational regulation of
ration into plasma cholesterol in female Nagase rats,this enzyme. HMG-CoA reductase is an endoplasmic
which exhibit a more severe hyperlipidemia than theirreticulum–bound enzyme that is the rate-controlling step
male counterpart. This was associated with a muchin cholesterol biosynthesis. While this enzyme is present
greater increase in the rate of biosynthesis of cholesterolin all tissues, it is most abundantly expressed in the liver,
and its main precursors in the carcass than in the liverwhich plays a central part in regulation of plasma choles-
terol concentration [17]. of their female NAR. These observations clearly indicate
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Fig. 3. Representative Western blot and group data depicting low-
density lipoprotein (LDL) receptor protein abundance in the liver of
Nagase rats with inherited analbuminemia (NAR) and Sprague Dawley
control (CTL) rats. N  6 in each group.
Fig. 5. Representative Western blot and group data depicting acyl-
coA cholesterol acyltransferase-2 (ACAT-2) protein abundance and
acyl-CoA cholesterol acyltransferase (ACAT) enzymatic activity in the
liver of Nagase rats with inherited analbuminemia (NAR) and Sprague
Dawley control (CTL) rats. N  6 in each group; *P  0.05.
for the associated hypercholesterolemia in their female
NAR.
The NAR group exhibited a significant up-regulation
of hepatic cholesterol 7-hydroxylase, which is the rate-
Fig. 4. Representative Western blot and group data depicting high-
limiting step in cholesterol conversion to bile acids fordensity lipoprotein (HDL) receptor (SRB-1) protein abundance in the
liver of Nagase rats with inherited analbuminemia (NAR) and Sprague disposal in the gut. Up-regulation of hepatic cholesterol
Dawley control (CTL) rats. N  6 in each group. 7-hydroxylase in NAR shown here provides the molec-
ular basis of the reported increased rate of fecal bile acid
excretion in this model [20]. Expression of cholesterol
7-hydroxylase is augmented by increased free choles-the role of increased total body cholesterol production
terol concentration in the hepatocyte [21, 22]. It is of notein the pathogenesis of hypercholesterolemia in female
that liver tissue free cholesterol concentration in our NARNAR rats. As with the present study, whole liver micro-
rats was nearly twice that of the Sprague Dawley controls.somal HMG-CoA reductase enzymatic activity in their
This phenomenon can account for the observed up-regula-female NAR was nearly identical to that found in their
tion of cholesterol 7-hydroxylase in our NAR. The com-Sprague Dawley control rats. Based on these observa-
pensatory up-regulation of cholesterol 7-hydroxylase,tions, the authors concluded that increased cholesterol
biosynthesis in extrahepatic tissues is largely responsible which is the main pathway of cholesterol catabolism, can
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can, in part, account for the greater severity of hypercho-
lesterolemia in the former compared to the latter condi-
tion.
Hepatic ACAT-2 protein abundance and ACAT ac-
tivity in NAR was mildly elevated compared to that
found in the Sprague Dawley control rats. ACAT cata-
lyzes the intracellular esterification of cholesterol-to-
cholesterol ester in nearly all mammalian cells [23]. Two
isoforms of this enzyme have been identified thus far,
including ACAT-1, which is expressed in most tissues
[24], and ACAT-2, which is primarily expressed in the
liver and intestine [25–27]. Esterification of cholesterol
in the liver by ACAT is involved in the packaging and
secretion of apoprotein B–containing lipoproteins
[28–30]. Mild up-regulation of hepatic ACAT-2 in our
NAR was associated with an increase in the intracellular
free cholesterol concentration. This observation suggests
that up-regulation of ACAT-2 may be a compensatory
response to increased hepatic tissue free cholesterol con-
centration. In our recent studies, we found a severe four-
fold increase in hepatic ACAT-2 abundance that was
accompanied by a significant reduction of hepatic tissue
free cholesterol concentration in rats with nephrotic
syndrome [12, 18}. Thus, severe up-regulation of hepatic
Fig. 6. Plasma concentration of the immunodetectable lecithin choles- ACAT-2 expression in nephrotic syndrome appears to rep-terol acyltransferase (LCAT) protein and enzymatic activity in the
resent a primary maladaptive phenomenon as opposed toNagase rats with hereditary analbuminemia (NAR) and Sprague Daw-
ley control (CTL) rats. N  6 in each group. an appropriate physiologic response seen in our rats with
hereditary analbuminemia.
Plasma LCAT protein concentration and enzymatic
activity in the NAR were virtually identical to those of
mitigate the impact of increased cholesterol biosynthesis the Sprague Dawley controls. LCAT is a glycoprotein
in the NAR. In contrast to rats with hereditary analbumi- enzyme that is produced in the liver and secreted in the
nemia, rats with nephrotic syndrome exhibit no rise in plasma. LCAT catalyzes hydrolysis of a free fatty acid
hepatic cholesterol 7-hydroxylase [10, 18]. Thus, the from phospholipid (phospholipase-2 activity) and trans-
presence of up-regulation of cholesterol 7-hydroxylase esterification of the fatty acid to the 3-hydroxyl group
in the NAR and its absence in nephrotic syndrome can, of cholesterol (acyltransferase activity) to produce cho-
in part, account for the greater severity of hypercholes- lesterol ester [31]. HDL is the preferred vehicle of LCAT
terolemia in nephrotic syndrome as compared to that in in the plasma and the primary platform for its reac-
hereditary analbuminemia. tions. By converting free cholesterol-to-cholesterol ester,
Hypercholesterolemia in hereditary analbuminemia is LCAT helps to maintain a favorable chemical concentra-
primarily due to increased LDL and HDL levels [4]. tion gradient for maximal efflux of cholesterol from the
Receptor-mediated uptake of LDL and HDL by the liver peripheral cells onto the surface of HDL particle. Thus,
represents the primary pathway of plasma cholesterol LCAT plays a central role in HDL-mediated transport
clearance. We therefore sought to determine the abun- of surplus cholesterol from peripheral tissues for disposal
dance of LDL receptor and HDL receptor, SRB-1, in in the liver. In fact, hereditary LCAT deficiency is associ-
the NAR. Hepatic LDL receptor and HDL receptor ated with significant reduction of plasma HDL choles-
proteins in the male NAR were virtually identical to terol concentration, formation of cholesterol-laden cells
those in Sprague-Dawley control rats. Thus, elevation in various tissues, corneal opacification, premature ath-
of plasma LDL and HDL cholesterol concentrations can- erosclerotic cardiovascular disease, and progressive re-
not be attributed to either LDL receptor or HDL recep- nal insufficiency [32]. In a recent study, we found heavy
tor deficiency. In contrast to the NAR, nephrotic animals urinary losses of LCAT leading to severe LCAT defi-
exhibit severe acquired LDL receptor and HDL receptor ciency in rats with nephrotic syndrome [18, 33]. This
deficiencies [11, 14, 18]. Once again, the presence of LDL phenomenon could account for impaired HDL matura-
receptor and HDL receptor deficiencies in nephrotic syn- tion and depressed HDL/total cholesterol ratio in ne-
phrotic syndrome. In contrast to the nephrotic rats, NARdrome and their absence in hereditary analbuminemia
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